A Pennsylvania mother and her one-year-old son share an unusual bond. They are both living with the same rare genetic disease. Lindsey Marson, 28, and her son, Bryson, were both born with ...
Neurofibromatosis type 1 (NF1) is a genetic condition that causes tumors to grow along nerves in the skin, brain, and other parts of the body. These tumors are usually noncancerous (benign), but they ...
Neurofibromatosis type 1 (NF1) is the most common of the three types of neurofibromatosis and is also one of the most common inherited neurological disorders, affecting about 1 in 3,000 people ...
19don MSN
Sally Nagappan celebrates resilience with annual ice cream tradition as FDA approves NF1 treatments
Sally Nagappan, living with NF1 since six months old, overcomes challenges with strength and community. Now, new treatments offer hope for others like her.
GOMEKLI is the first FDA-approved treatment for adult and pediatric NF1-PN, showing effective tumor reduction and manageable safety. SpringWorks Therapeutics has announced the FDA approval of GOMEKLI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback